UTokyo Innovation Platform Company

Instalimb, Inc. is a pioneering company based in Tokyo, Japan, specializing in the development of low-cost 3D printed prosthetics and orthotics. Leveraging advanced 3D-CAD, 3D printing, and machine learning technologies, Instalimb aims to revolutionize the prosthetics industry by significantly reducing production costs and delivery times. The company utilizes an innovative algorithm that enhances design efficiency, allowing for the creation of customized prosthetic devices tailored to individual needs. This cutting-edge approach not only makes prosthetics more accessible to amputees but also represents a significant advancement in the field of assistive technology. As the world's first business dedicated to 3D printed prostheses, Instalimb is committed to improving the quality of life for individuals requiring these essential devices.

Founded in 2013, Ubitus specializes in deploying cloud-enabled rich media services. It offers a leading cloud gaming solution for major game companies and telecom service providers worldwide. Additionally, it streams metaverse content across multiple devices for platform operators and digital content developers.

Leading Mark Inc. is an employment agency based in Tokyo, Japan, specializing in human resources services. The company is focused on streamlining the recruitment process through its online platform, which aggregates job listings tailored to users' interests. This approach aims to enhance the job-seeking experience by prioritizing the needs of applicants, in contrast to larger, traditional agencies that may focus more on the hiring companies. Additionally, Leading Mark is expanding its operations to include mid-career and international hiring, with a dedicated team in China working to connect top Japanese-speaking Chinese students with domestic employers. By emphasizing a user-centric model, Leading Mark seeks to alleviate the frustrations often faced by job seekers, ensuring they receive the information and opportunities they need to advance their careers.

LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.

Founded in Tokyo, Japan in 2017, Girasol Energy develops an IoT platform for photovoltaic plants. It installs sensor networks, collects data at the panel level via its cloud engine, and uses AI to automatically detect anomalies. The company's exclusive technology leverages satellite-based solar radiation statistics, enabling it to offer services at a significantly lower price compared to competitors.

Heartseed Inc. is a Tokyo-based biotechnology company founded in 2015, focused on developing myocardial regeneration medicine utilizing induced pluripotent stem (iPS) cells. The company's mission is to advance treatments for heart disease through regenerative medicine, specifically targeting advanced heart failure with iPS cell-derived cardiomyocyte replacement therapy. Heartseed aims to enable the clinical application of its innovative therapies to improve outcomes for patients suffering from heart conditions.

BionicM is a Tokyo‑based company that develops robotic prostheses for lower‑limb amputees. Its products include powered knee joints and ankle‑foot devices that mimic natural muscle function, allowing users to stand, walk, and climb stairs with reduced effort. The company’s technology was first researched in 2015 at the University of Tokyo’s Information Systems Engineering Laboratory and received support from the Japan Science and Technology Agency in 2016. BionicM was formally established in 2018 and continues to advance high‑performance prosthetic solutions that enhance mobility for people with disabilities.

Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.

Alivexis is a private preclinical stage drug discovery company based in Tokyo, specializing in the rapid design and generation of small molecule clinical candidates targeting high-value disease conditions. The company leverages advanced computational drug discovery techniques and unique biological insights to expedite the development of new medicines. Its international team comprises experts in drug design and disease biology, drawing on extensive research and development experience from global pharmaceutical, biotechnology, and technology firms. By focusing on innovative approaches, Alivexis aims to enhance biotechnological research and improve the efficiency of delivering essential medicines to patients with unmet medical needs.

Heartseed Inc. is a Tokyo-based biotechnology company founded in 2015, focused on developing myocardial regeneration medicine utilizing induced pluripotent stem (iPS) cells. The company's mission is to advance treatments for heart disease through regenerative medicine, specifically targeting advanced heart failure with iPS cell-derived cardiomyocyte replacement therapy. Heartseed aims to enable the clinical application of its innovative therapies to improve outcomes for patients suffering from heart conditions.

LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.

Sonas Inc. is a Tokyo-based company specializing in the planning, design, manufacturing, and sale of innovative hardware and software solutions for sensing and measurement. The company is developing its UNISONet technology, which aims to enhance the Internet of Things (IoT) by providing high-quality wireless sensing capabilities. This technology addresses traditional challenges in IoT communications by utilizing advanced features such as power-saving mechanisms, high-speed data acquisition, low-latency bidirectional communication, and robust retransmission controls to prevent data loss. Sonas's solutions enable the sensing of various parameters, from small-scale measurements like temperature and humidity to larger-scale data such as acceleration and images, thereby positioning the company as a key player in the evolving IoT landscape.

Founded in 2016, RIN Institute is a Japanese biotechnology company dedicated to the research and development of antibody-based medicines and external diagnostic drugs. Its primary focus is on developing monoclonal antibodies for cancer diagnostics and therapeutics.

BionicM is a Tokyo‑based company that develops robotic prostheses for lower‑limb amputees. Its products include powered knee joints and ankle‑foot devices that mimic natural muscle function, allowing users to stand, walk, and climb stairs with reduced effort. The company’s technology was first researched in 2015 at the University of Tokyo’s Information Systems Engineering Laboratory and received support from the Japan Science and Technology Agency in 2016. BionicM was formally established in 2018 and continues to advance high‑performance prosthetic solutions that enhance mobility for people with disabilities.

Adriakaim Inc. is a Tokyo-based company established in 2018 that specializes in the research, design, development, manufacture, and sale of medical and health-related equipment. In addition to its core product offerings, Adriakaim provides consulting services focused on management and technology strategy, specifically within the medical device sector. The company also supports research and development processes, contributing to advancements in healthcare technology.

Alivexis is a private preclinical stage drug discovery company based in Tokyo, specializing in the rapid design and generation of small molecule clinical candidates targeting high-value disease conditions. The company leverages advanced computational drug discovery techniques and unique biological insights to expedite the development of new medicines. Its international team comprises experts in drug design and disease biology, drawing on extensive research and development experience from global pharmaceutical, biotechnology, and technology firms. By focusing on innovative approaches, Alivexis aims to enhance biotechnological research and improve the efficiency of delivering essential medicines to patients with unmet medical needs.

Founded in 2014, Aidemy offers an online platform for individuals to learn artificial intelligence programming and for businesses to leverage AI technology using their own data. Its services include practical blockchain applications, supporting DX human resource development, problem selection, proof-of-concept development, and operation.

Synspective specializes in developing and operating small synthetic aperture radar (SAR) satellites, providing SAR data and remote monitoring services. It caters to urban design, infrastructure, energy, insurance, finance sectors, and government agencies.

Connected Robotics Inc., founded in 2014 and based in Koganei-shi, Japan, specializes in designing and manufacturing robotic arms for enterprises. Their flagship product, OctoChef, is a cooking robot designed to address labor shortages in the restaurant industry. Utilizing artificial intelligence, image processing, and robot control technologies, OctoChef aims to enhance efficiency and worker satisfaction by automating kitchen tasks. The company serves a variety of clients, including individual restaurants, shopping malls, stations, service areas, amusement centers, and large-scale events, providing fun and healthy meal options while contributing to societal improvements.

EdiGENE Japan, now known as Modalis Therapeutics Corporation, is an emerging biotechnology company based in Tokyo, Japan. Founded in 2016, it specializes in the research and development of innovative therapeutics aimed at addressing serious genetic disorders. The company utilizes its proprietary CRISPR-GNDM technology, which allows for locus-specific modulation of gene expression and histone modification without the necessity for double-stranded DNA cleavage or traditional gene editing techniques. Modalis Therapeutics has established a solid intellectual property foundation, including licenses from the University of Tokyo, to support its focus on developing treatments for orphan genetic diseases and other unmet medical needs.

Founded in 2006, QD Laser specializes in manufacturing quantum dot semiconductor lasers and wafers for various applications such as communications, industrial processing, and medical imaging. Its product portfolio includes picosecond lasers for precision machining, color-specific lasers for biological sciences, laser arrays for silicon optical circuits, and broadband gain chips for ophthalmic testing. Headquartered in Kawasaki, Japan, the company serves diverse industries including telecommunications, manufacturing, medicine, and consumer products.

Crewt Medical Systems, established in Tokyo, Japan in 2013, specializes in manufacturing innovative medical devices. The company's flagship product is the world's first head-mounted perimeter, designed to meet clinical needs and compatible with standard automated perimeters. Crewt's mission is to create new value in healthcare by integrating advanced technologies, focusing on human-centric solutions that enhance visual quality.

Synspective specializes in developing and operating small synthetic aperture radar (SAR) satellites, providing SAR data and remote monitoring services. It caters to urban design, infrastructure, energy, insurance, finance sectors, and government agencies.

Founded in 2006, QD Laser specializes in manufacturing quantum dot semiconductor lasers and wafers for various applications such as communications, industrial processing, and medical imaging. Its product portfolio includes picosecond lasers for precision machining, color-specific lasers for biological sciences, laser arrays for silicon optical circuits, and broadband gain chips for ophthalmic testing. Headquartered in Kawasaki, Japan, the company serves diverse industries including telecommunications, manufacturing, medicine, and consumer products.

Braizon Therapeutics, Inc. is a biopharmaceutical company based in Tokyo, Japan, founded in 2015. It focuses on the research and development of innovative drug delivery technologies specifically aimed at treating central nervous system disorders. The company was established through collaborative research efforts led by prominent academics from the University of Tokyo and Tokyo Medical and Dental University. Braizon’s primary objective is to create effective methods for delivering therapeutic drugs across the blood-brain barrier, thereby addressing the challenges associated with treating incurable neuronal diseases. Through its advanced platform, Braizon Therapeutics seeks to enhance the efficacy of treatments for patients suffering from various central nervous system conditions.

Alivas is a medical device company based in Tokyo, Japan, that develops a therapeutic device to treat refractory constipation. Founded in 2017, the company aims to provide a treatment option for patients with intractable chronic constipation. It is described as a joint venture between Stanford University and the University of Tokyo, in collaboration with the Japan Biodesign program for innovative medical device creation.

Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin technology, which integrates wearable electronics into apparel. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and flexible devices that can seamlessly interface with the human body. The company's innovative clothing line incorporates highly sensitive motion sensors capable of monitoring movement, posture, breathing, and body temperature, while also being durable and machine washable. By collecting accurate data from these sensors, Xenoma aims to enhance healthcare through the integration of big data and IoT solutions, ultimately providing users with comfortable and functional wearable technology.

Crewt Medical Systems, established in Tokyo, Japan in 2013, specializes in manufacturing innovative medical devices. The company's flagship product is the world's first head-mounted perimeter, designed to meet clinical needs and compatible with standard automated perimeters. Crewt's mission is to create new value in healthcare by integrating advanced technologies, focusing on human-centric solutions that enhance visual quality.